Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies-Reference-Cited by-同舟云学术

Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies

Published:2013-07 Issue:20 Volume:34 Page:4831-4838
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Hillaireau Hervé,Dereuddre-Bosquet Nathalie,Skanji Rym,Bekkara-Aounallah Fawzia,Caron Joachim,Lepêtre Sinda,Argote Sébastien,Bauduin Laurent,Yousfi Rahima,Rogez-Kreuz Christine,Desmaële Didier,Rousseau Bernard,Gref Ruxandra,Andrieux Karine,Clayette Pascal,Couvreur Patrick

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference17 articles.

1. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead;Sosnik;J Control Release,2009

2. Antiviral nucleoside analogs phosphorylation by nucleoside diphosphate kinase;Gallois-Montbrun;Mini Rev Med Chem,2004

3. Strategies in the design of prodrugs of anti-HIV agents;Calogeropoulou;Curr Top Med Chem,2003

4. A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary;Skanji;Int J Pharm,2011

5. Polymer-based nanoparticles for the delivery of nucleoside analogues;Hillaireau;J Nanosci Nanotechno,2006

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembled lipid–prodrug nanoparticles;Nature Reviews Bioengineering;2023-06-28

2. Inhalable Prodrugs for Pulmonary Therapeutics;Pulmonary Drug Delivery Systems: Material and Technological Advances;2023

3. Nanoparticle-based strategies to target HIV-infected cells;Colloids and Surfaces B: Biointerfaces;2022-05

4. Prodrug Therapies for Infectious and Neurodegenerative Diseases;Pharmaceutics;2022-02-26

5. Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections;Pharmaceutical Research;2022-02-10